Confo Therapeutics is an emerging drug discovery company built around a disruptive technology to enable the discovery of GPCR agonists. The CONFO® technology uses single domain antibodies to lock inherently unstable GPCRs in the druggable conformation and uses this stabilized complex as a superior starting point for GPCR drug discovery. 



Biotechnology

Confo Therapeutics

Cedric Ververken

Geert Degruyter

Frederik Dutoit

Bruno Ranschaert

Thomas Fontaine

Richa Virmani

Caroline Segers

Andreas Busch

Stephen Dowd

Christel Menet

Frank Landolt

Paolo Vicini

Stephanie Staelens

Marc Moens

Confo Therapeutics' Founding Team includes Jan Steyaert.

Founding Team

Board of Directors

Leadership Team

CEO and Executive Team

Founding Team

About

Team members

Other teams at Confo Therapeutics

Board of Directors

Leadership Team

CEO and Executive Team